FN2 Earnings Intelligence

TG Therapeutics, Inc. ratios (quarterly)

TG Therapeutics, Inc. (TGTX) Ratios (quarterly) derived from persisted SEC financial facts.

Ratios

USD in millions, except per-share values and percentages.

Metric 3/31/20256/30/20259/30/20253/31/20269/30/2026
Revenue Growth 90.4%92.1%92.8%69.6%60.7%
Gross Margin 87.1%86.6%82.6%83.6%83.8%
EBITDA Margin 7.1%--17.0%-
Net Margin 4.2%20.0%241.7%9.7%21.3%
FCF Margin -23.8%---8.8%-
Diluted EPS Growth -325.0%12,050.0%300.0%-85.6%

Get the TGTX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.